Millennium Management »

Adaptimmune Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $350k 441k 0.79
2023-09-30 $234k 300k 0.78
2023-06-30 $603k 652k 0.93
2023-03-31 $327k 300k 1.09
2022-12-31 $240k 165k 1.46
2022-06-30 $208k 122k 1.70
2022-03-31 $3.0M 1.4M 2.06
2021-09-30 $8.2M 1.6M 5.17
2021-06-30 $4.0M 930k 4.26
2021-03-31 $8.6M 1.6M 5.31
2020-12-31 $9.3M 1.7M 5.39
2020-09-30 $5.6M 705k 7.98
2020-06-30 $18M 1.8M 10.01
2020-03-31 $4.0M 1.5M 2.72
2019-12-31 $592k 493k 1.20
2019-09-30 $1.4M 914k 1.51
2019-06-30 $36M 869k 41.11
2019-03-31 $11M 2.6M 4.30
2018-12-31 $13M 2.3M 5.75
2018-09-30 $38M 2.8M 13.56
2018-06-30 $11M 944k 11.87
2018-03-31 $17M 1.5M 11.23
2017-12-31 $5.4M 806k 6.68
2017-09-30 $4.8M 590k 8.19
2017-06-30 $1.1M 248k 4.49
2017-03-31 $4.0M 720k 5.51
2016-12-31 $2.7M 672k 4.05
2016-09-30 $4.6M 647k 7.05
2016-06-30 $5.5M 675k 8.15
2016-03-31 $7.5M 917k 8.13
2015-12-31 $4.2M 345k 12.06
2015-09-30 $2.2M 188k 11.97
2015-06-30 $2.2M 118k 18.33